Asieris Pharmaceuticals

OverviewSuggest Edit

Asieris Pharmaceuticals is a biotech company that specializes in the development and commercialization of pharmaceutical drugs. It aims to provide treatment for genitourinary tumors and related diseases. Asieris has research and development platforms for anti-tumor and anti-microbial resistance drugs.
TypePrivate
Founded2010
HQShanghai, CN
Websiteasieris.cn

Latest Updates

Employees (est.) (Aug 2022)41(-2%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Asieris Pharmaceuticals Office Locations

Asieris Pharmaceuticals has offices in Shanghai and Wayne
Shanghai, CN (HQ)
8F Building, 1000 Jinhai Rd, Pudong Xinqu
Wayne, PA, US
201 King of Prussia Rd #650
Show all (2)

Asieris Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

2010

Asieris Pharmaceuticals total Funding

$135.3 m

Asieris Pharmaceuticals latest funding size

$106 m

Time since last funding

2 years ago

Asieris Pharmaceuticals investors

Asieris Pharmaceuticals's latest funding round in November 2020 was reported to be $106 m. In total, Asieris Pharmaceuticals has raised $135.3 m
Show all financial metrics

Asieris Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Asieris Pharmaceuticals Online and Social Media Presence

Embed Graph

Asieris Pharmaceuticals News and Updates

Asieris Pharmaceuticals Announces 2021 Annual Report: Steady Progress in Core Product Pipeline and Progressive Implementation of the Integrated Diagnosis and Treatment Commercialization Strategy

SHANGHAI, April 14, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (688176.SH), a global innovative pharmaceutical company specializing in the treatment of genitourinary cancers and related major diseases, announced its 2021 annual report today. The company is currently making steady...

China’s Asieris Pharmaceuticals Bags Over $106m Funding Led by Qiming

Genitourinary tumor therapy developer Asieris Pharmaceuticals has closed a Series D round of financing raising over 700 million yuan ($106 million) led by Chinese global venture capital firm Qiming Venture Partners, according to a company statement on Wednesday

Asieris Pharmaceuticals Frequently Asked Questions

  • When was Asieris Pharmaceuticals founded?

    Asieris Pharmaceuticals was founded in 2010.

  • How many employees does Asieris Pharmaceuticals have?

    Asieris Pharmaceuticals has 41 employees.

  • Who are Asieris Pharmaceuticals competitors?

    Competitors of Asieris Pharmaceuticals include The Searle Company, Bio Farma and Relay Therapeutics.

  • Where is Asieris Pharmaceuticals headquarters?

    Asieris Pharmaceuticals headquarters is located at 8F Building, 1000 Jinhai Rd, Pudong Xinqu, Shanghai.

  • Where are Asieris Pharmaceuticals offices?

    Asieris Pharmaceuticals has offices in Shanghai and Wayne.

  • How many offices does Asieris Pharmaceuticals have?

    Asieris Pharmaceuticals has 2 offices.